HEADER TRANSFERASE 24-MAR-23 8GMC TITLE CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4- TITLE 2 AMINOPIPERIDIN-1-YL)METHYL]-N-{3-[5-(PROPAN-2-YL)-1,3,4-THIADIAZOL-2- TITLE 3 YL]PHENYL}PYRROLO[2,1-F][1,2,4]TRIAZIN-4-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AP2-ASSOCIATED PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADAPTOR-ASSOCIATED KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AAK1, KIAA1048; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS AP2 ASSOCIATED KINASE 1, AAK1, KINASE, LIGAND INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 2 25-OCT-23 8GMC 1 REMARK REVDAT 1 12-JUL-23 8GMC 0 JRNL AUTH C.D.DZIERBA,B.DASGUPTA,G.KARAGEORGE,W.KOSTICH,B.HAMMAN, JRNL AUTH 2 J.ALLEN,K.M.ESPOSITO,R.PADMANABHA,J.GRACE,K.LENTZ, JRNL AUTH 3 J.MORRISON,D.MORGAN,A.EASTON,C.BOURIN,M.R.BROWNING, JRNL AUTH 4 R.RAJAMANI,A.GOOD,D.D.PARKER,J.K.MUCKELBAUER,J.KHAN,D.CAMAC, JRNL AUTH 5 K.GHOSH,V.HALAN,J.S.LIPPY,K.S.SANTONE,R.R.DENTON,R.WESTPHAL, JRNL AUTH 6 L.J.BRISTOW,C.M.CONWAY,J.J.BRONSON,J.E.MACOR JRNL TITL DISCOVERY OF PYRROLO[2,1- F ][1,2,4]TRIAZINE-BASED JRNL TITL 2 INHIBITORS OF ADAPTOR PROTEIN 2-ASSOCIATED KINASE 1 FOR THE JRNL TITL 3 TREATMENT OF PAIN. JRNL REF MED.CHEM.RES. 1 2023 JRNL REFN ISSN 1054-2523 JRNL PMID 37362320 JRNL DOI 10.1007/S00044-023-03079-X REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 31551 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1592 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2854 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2696 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2714 REMARK 3 BIN R VALUE (WORKING SET) : 0.2672 REMARK 3 BIN FREE R VALUE : 0.3142 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.91 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4442 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 74 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.25120 REMARK 3 B22 (A**2) : -4.25120 REMARK 3 B33 (A**2) : 8.50250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.381 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.237 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.913 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4618 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6281 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1523 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 107 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 724 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4618 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 615 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5275 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.14 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8GMC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000273182. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31551 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.63300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7RJ6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M AMSO4, 0.1M TRI-NA CITRATE PH REMARK 280 6.0, 3% ISOPROPANOL, 296K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 155.42500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.38900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.38900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 77.71250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.38900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.38900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 233.13750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.38900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.38900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 77.71250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.38900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.38900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 233.13750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 155.42500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 LEU A 20 REMARK 465 VAL A 21 REMARK 465 PRO A 22 REMARK 465 ARG A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 THR A 27 REMARK 465 SER A 28 REMARK 465 GLY A 29 REMARK 465 LEU A 30 REMARK 465 GLY A 31 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 96 REMARK 465 LEU A 97 REMARK 465 SER A 98 REMARK 465 ASP A 186 REMARK 465 MET B 13 REMARK 465 HIS B 14 REMARK 465 HIS B 15 REMARK 465 HIS B 16 REMARK 465 HIS B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 LEU B 20 REMARK 465 VAL B 21 REMARK 465 PRO B 22 REMARK 465 ARG B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 SER B 26 REMARK 465 THR B 27 REMARK 465 SER B 28 REMARK 465 GLY B 29 REMARK 465 LEU B 30 REMARK 465 GLY B 42 REMARK 465 ASP B 186 REMARK 465 ARG B 187 REMARK 465 ASP B 278 REMARK 465 ASN B 279 REMARK 465 SER B 280 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 43 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 54 CG CD OE1 OE2 REMARK 470 MET A 69 CG SD CE REMARK 470 LYS A 70 CG CD CE NZ REMARK 470 ASN A 79 CG OD1 ND2 REMARK 470 ASN A 80 CG OD1 ND2 REMARK 470 GLU A 81 CG CD OE1 OE2 REMARK 470 HIS A 82 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A 83 CG OD1 OD2 REMARK 470 GLN A 85 CG CD OE1 NE2 REMARK 470 VAL A 86 CG1 CG2 REMARK 470 ARG A 89 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 92 CG CD OE1 NE2 REMARK 470 ARG A 130 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 140 CG CD OE1 NE2 REMARK 470 ARG A 141 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 143 CG CD OE1 NE2 REMARK 470 THR A 144 OG1 CG2 REMARK 470 LYS A 169 CG CD CE NZ REMARK 470 HIS A 185 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 187 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 200 CG OD1 ND2 REMARK 470 LYS A 201 CG CD CE NZ REMARK 470 GLN A 206 CG CD OE1 NE2 REMARK 470 LYS A 218 CG CD CE NZ REMARK 470 ASP A 278 CG OD1 OD2 REMARK 470 ASN A 279 CG OD1 ND2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 300 CE NZ REMARK 470 LYS A 313 CG CD CE NZ REMARK 470 LYS A 316 CD CE NZ REMARK 470 LYS A 317 CD CE NZ REMARK 470 GLU A 318 CG CD OE1 OE2 REMARK 470 ILE A 329 CG1 CG2 CD1 REMARK 470 ARG B 37 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 43 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 45 CG CD OE1 NE2 REMARK 470 ARG B 64 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 89 CZ NH1 NH2 REMARK 470 VAL B 114 CG1 CG2 REMARK 470 GLN B 140 CD OE1 NE2 REMARK 470 LEU B 142 CG CD1 CD2 REMARK 470 GLN B 143 CG CD OE1 NE2 REMARK 470 THR B 144 OG1 CG2 REMARK 470 LYS B 169 CG CD CE NZ REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 201 CG CD CE NZ REMARK 470 GLN B 206 CG CD OE1 NE2 REMARK 470 LYS B 218 CG CD CE NZ REMARK 470 LYS B 219 CD CE NZ REMARK 470 THR B 259 OG1 CG2 REMARK 470 LEU B 260 CG CD1 CD2 REMARK 470 THR B 275 OG1 CG2 REMARK 470 ILE B 276 CG1 CG2 CD1 REMARK 470 ARG B 281 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 284 CG CD OE1 NE2 REMARK 470 ASP B 285 CG OD1 OD2 REMARK 470 ARG B 291 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 317 CD CE NZ REMARK 470 GLU B 318 CG CD OE1 OE2 REMARK 470 ASN B 326 CG OD1 ND2 REMARK 470 ILE B 329 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 175 -0.05 71.44 REMARK 500 ASP A 176 49.57 -146.90 REMARK 500 ASP A 194 102.47 63.58 REMARK 500 THR A 240 -164.14 -129.14 REMARK 500 SER B 98 -165.54 -79.75 REMARK 500 ARG B 175 -5.73 71.41 REMARK 500 ASP B 176 49.86 -143.55 REMARK 500 ASP B 194 102.24 62.85 REMARK 500 THR B 240 -163.62 -125.96 REMARK 500 PHE B 258 19.40 56.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 8GMC A 26 330 UNP Q2M2I8 AAK1_HUMAN 26 330 DBREF 8GMC B 26 330 UNP Q2M2I8 AAK1_HUMAN 26 330 SEQADV 8GMC MET A 13 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 14 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 15 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 16 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 17 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 18 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS A 19 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC LEU A 20 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC VAL A 21 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC PRO A 22 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC ARG A 23 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC GLY A 24 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC SER A 25 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC MET B 13 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 14 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 15 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 16 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 17 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 18 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC HIS B 19 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC LEU B 20 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC VAL B 21 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC PRO B 22 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC ARG B 23 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC GLY B 24 UNP Q2M2I8 EXPRESSION TAG SEQADV 8GMC SER B 25 UNP Q2M2I8 EXPRESSION TAG SEQRES 1 A 318 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 A 318 SER THR SER GLY LEU GLY SER GLY TYR ILE GLY ARG VAL SEQRES 3 A 318 PHE GLY ILE GLY ARG GLN GLN VAL THR VAL ASP GLU VAL SEQRES 4 A 318 LEU ALA GLU GLY GLY PHE ALA ILE VAL PHE LEU VAL ARG SEQRES 5 A 318 THR SER ASN GLY MET LYS CYS ALA LEU LYS ARG MET PHE SEQRES 6 A 318 VAL ASN ASN GLU HIS ASP LEU GLN VAL CYS LYS ARG GLU SEQRES 7 A 318 ILE GLN ILE MET ARG ASP LEU SER GLY HIS LYS ASN ILE SEQRES 8 A 318 VAL GLY TYR ILE ASP SER SER ILE ASN ASN VAL SER SER SEQRES 9 A 318 GLY ASP VAL TRP GLU VAL LEU ILE LEU MET ASP PHE CYS SEQRES 10 A 318 ARG GLY GLY GLN VAL VAL ASN LEU MET ASN GLN ARG LEU SEQRES 11 A 318 GLN THR GLY PHE THR GLU ASN GLU VAL LEU GLN ILE PHE SEQRES 12 A 318 CYS ASP THR CYS GLU ALA VAL ALA ARG LEU HIS GLN CYS SEQRES 13 A 318 LYS THR PRO ILE ILE HIS ARG ASP LEU LYS VAL GLU ASN SEQRES 14 A 318 ILE LEU LEU HIS ASP ARG GLY HIS TYR VAL LEU CYS ASP SEQRES 15 A 318 PHE GLY SER ALA THR ASN LYS PHE GLN ASN PRO GLN THR SEQRES 16 A 318 GLU GLY VAL ASN ALA VAL GLU ASP GLU ILE LYS LYS TYR SEQRES 17 A 318 THR THR LEU SER TYR ARG ALA PRO GLU MET VAL ASN LEU SEQRES 18 A 318 TYR SER GLY LYS ILE ILE THR THR LYS ALA ASP ILE TRP SEQRES 19 A 318 ALA LEU GLY CYS LEU LEU TYR LYS LEU CYS TYR PHE THR SEQRES 20 A 318 LEU PRO PHE GLY GLU SER GLN VAL ALA ILE CYS ASP GLY SEQRES 21 A 318 ASN PHE THR ILE PRO ASP ASN SER ARG TYR SER GLN ASP SEQRES 22 A 318 MET HIS CYS LEU ILE ARG TYR MET LEU GLU PRO ASP PRO SEQRES 23 A 318 ASP LYS ARG PRO ASP ILE TYR GLN VAL SER TYR PHE SER SEQRES 24 A 318 PHE LYS LEU LEU LYS LYS GLU CYS PRO ILE PRO ASN VAL SEQRES 25 A 318 GLN ASN SER PRO ILE PRO SEQRES 1 B 318 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 B 318 SER THR SER GLY LEU GLY SER GLY TYR ILE GLY ARG VAL SEQRES 3 B 318 PHE GLY ILE GLY ARG GLN GLN VAL THR VAL ASP GLU VAL SEQRES 4 B 318 LEU ALA GLU GLY GLY PHE ALA ILE VAL PHE LEU VAL ARG SEQRES 5 B 318 THR SER ASN GLY MET LYS CYS ALA LEU LYS ARG MET PHE SEQRES 6 B 318 VAL ASN ASN GLU HIS ASP LEU GLN VAL CYS LYS ARG GLU SEQRES 7 B 318 ILE GLN ILE MET ARG ASP LEU SER GLY HIS LYS ASN ILE SEQRES 8 B 318 VAL GLY TYR ILE ASP SER SER ILE ASN ASN VAL SER SER SEQRES 9 B 318 GLY ASP VAL TRP GLU VAL LEU ILE LEU MET ASP PHE CYS SEQRES 10 B 318 ARG GLY GLY GLN VAL VAL ASN LEU MET ASN GLN ARG LEU SEQRES 11 B 318 GLN THR GLY PHE THR GLU ASN GLU VAL LEU GLN ILE PHE SEQRES 12 B 318 CYS ASP THR CYS GLU ALA VAL ALA ARG LEU HIS GLN CYS SEQRES 13 B 318 LYS THR PRO ILE ILE HIS ARG ASP LEU LYS VAL GLU ASN SEQRES 14 B 318 ILE LEU LEU HIS ASP ARG GLY HIS TYR VAL LEU CYS ASP SEQRES 15 B 318 PHE GLY SER ALA THR ASN LYS PHE GLN ASN PRO GLN THR SEQRES 16 B 318 GLU GLY VAL ASN ALA VAL GLU ASP GLU ILE LYS LYS TYR SEQRES 17 B 318 THR THR LEU SER TYR ARG ALA PRO GLU MET VAL ASN LEU SEQRES 18 B 318 TYR SER GLY LYS ILE ILE THR THR LYS ALA ASP ILE TRP SEQRES 19 B 318 ALA LEU GLY CYS LEU LEU TYR LYS LEU CYS TYR PHE THR SEQRES 20 B 318 LEU PRO PHE GLY GLU SER GLN VAL ALA ILE CYS ASP GLY SEQRES 21 B 318 ASN PHE THR ILE PRO ASP ASN SER ARG TYR SER GLN ASP SEQRES 22 B 318 MET HIS CYS LEU ILE ARG TYR MET LEU GLU PRO ASP PRO SEQRES 23 B 318 ASP LYS ARG PRO ASP ILE TYR GLN VAL SER TYR PHE SER SEQRES 24 B 318 PHE LYS LEU LEU LYS LYS GLU CYS PRO ILE PRO ASN VAL SEQRES 25 B 318 GLN ASN SER PRO ILE PRO HET YFV A 401 32 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET YFV B 401 32 HET SO4 B 402 5 HETNAM YFV 5-[(4-AMINOPIPERIDIN-1-YL)METHYL]-N-{3-[5-(PROPAN-2- HETNAM 2 YFV YL)-1,3,4-THIADIAZOL-2-YL]PHENYL}PYRROLO[2,1-F][1,2, HETNAM 3 YFV 4]TRIAZIN-4-AMINE HETNAM SO4 SULFATE ION FORMUL 3 YFV 2(C23 H28 N8 S) FORMUL 4 SO4 4(O4 S 2-) FORMUL 9 HOH *74(H2 O) HELIX 1 AA1 ASN A 80 ARG A 95 1 16 HELIX 2 AA2 GLN A 133 ARG A 141 1 9 HELIX 3 AA3 THR A 147 GLN A 167 1 21 HELIX 4 AA4 LYS A 178 GLU A 180 5 3 HELIX 5 AA5 ASN A 204 GLY A 209 1 6 HELIX 6 AA6 GLY A 209 THR A 221 1 13 HELIX 7 AA7 THR A 222 ARG A 226 5 5 HELIX 8 AA8 ALA A 227 ASN A 232 1 6 HELIX 9 AA9 THR A 241 PHE A 258 1 18 HELIX 10 AB1 SER A 265 GLY A 272 1 8 HELIX 11 AB2 SER A 283 LEU A 294 1 12 HELIX 12 AB3 ASP A 303 LYS A 316 1 14 HELIX 13 AB4 ASN B 80 LEU B 97 1 18 HELIX 14 AB5 GLN B 133 ARG B 141 1 9 HELIX 15 AB6 THR B 147 GLN B 167 1 21 HELIX 16 AB7 LYS B 178 GLU B 180 5 3 HELIX 17 AB8 ASN B 204 GLY B 209 1 6 HELIX 18 AB9 GLY B 209 THR B 221 1 13 HELIX 19 AC1 THR B 222 ARG B 226 5 5 HELIX 20 AC2 ALA B 227 ASN B 232 1 6 HELIX 21 AC3 THR B 241 PHE B 258 1 18 HELIX 22 AC4 SER B 265 GLY B 272 1 8 HELIX 23 AC5 SER B 283 LEU B 294 1 12 HELIX 24 AC6 ASP B 303 LYS B 316 1 14 SHEET 1 AA1 8 TYR A 106 SER A 115 0 SHEET 2 AA1 8 VAL A 119 ASP A 127 -1 O LEU A 125 N ASP A 108 SHEET 3 AA1 8 LYS A 70 VAL A 78 -1 N MET A 76 O VAL A 122 SHEET 4 AA1 8 ALA A 58 THR A 65 -1 N ILE A 59 O ARG A 75 SHEET 5 AA1 8 GLN A 44 GLY A 55 -1 N ALA A 53 O VAL A 60 SHEET 6 AA1 8 VAL A 38 ILE A 41 -1 N ILE A 41 O GLN A 44 SHEET 7 AA1 8 GLN B 45 GLY B 55 1 O GLU B 54 N VAL A 38 SHEET 8 AA1 8 VAL B 38 GLY B 40 -1 N PHE B 39 O VAL B 46 SHEET 1 AA211 TYR A 106 SER A 115 0 SHEET 2 AA211 VAL A 119 ASP A 127 -1 O LEU A 125 N ASP A 108 SHEET 3 AA211 LYS A 70 VAL A 78 -1 N MET A 76 O VAL A 122 SHEET 4 AA211 ALA A 58 THR A 65 -1 N ILE A 59 O ARG A 75 SHEET 5 AA211 GLN A 44 GLY A 55 -1 N ALA A 53 O VAL A 60 SHEET 6 AA211 VAL A 38 ILE A 41 -1 N ILE A 41 O GLN A 44 SHEET 7 AA211 GLN B 45 GLY B 55 1 O GLU B 54 N VAL A 38 SHEET 8 AA211 ALA B 58 THR B 65 -1 O VAL B 60 N LEU B 52 SHEET 9 AA211 LYS B 70 VAL B 78 -1 O ARG B 75 N ILE B 59 SHEET 10 AA211 TRP B 120 ASP B 127 -1 O TRP B 120 N VAL B 78 SHEET 11 AA211 TYR B 106 ASN B 113 -1 N ASP B 108 O LEU B 125 SHEET 1 AA3 2 ILE A 182 LEU A 184 0 SHEET 2 AA3 2 TYR A 190 LEU A 192 -1 O VAL A 191 N LEU A 183 SHEET 1 AA4 2 ILE B 182 LEU B 184 0 SHEET 2 AA4 2 TYR B 190 LEU B 192 -1 O VAL B 191 N LEU B 183 CISPEP 1 SER B 98 GLY B 99 0 15.42 CRYST1 74.778 74.778 310.850 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013373 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013373 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003217 0.00000